ATE134873T1 - Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung - Google Patents

Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung

Info

Publication number
ATE134873T1
ATE134873T1 AT92107277T AT92107277T ATE134873T1 AT E134873 T1 ATE134873 T1 AT E134873T1 AT 92107277 T AT92107277 T AT 92107277T AT 92107277 T AT92107277 T AT 92107277T AT E134873 T1 ATE134873 T1 AT E134873T1
Authority
AT
Austria
Prior art keywords
compounds
parenteral administration
lambda
warm
alpha
Prior art date
Application number
AT92107277T
Other languages
English (en)
Inventor
Susan Mancini Cady
William David Steber
Phillip Wayne Hayes
Mary Ehlers Doscher
Kurt Allen Schwinghammer
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE134873T1 publication Critical patent/ATE134873T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92107277T 1991-07-23 1992-04-29 Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung ATE134873T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73443091A 1991-07-23 1991-07-23

Publications (1)

Publication Number Publication Date
ATE134873T1 true ATE134873T1 (de) 1996-03-15

Family

ID=24951666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92107277T ATE134873T1 (de) 1991-07-23 1992-04-29 Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung

Country Status (21)

Country Link
US (1) US6340671B1 (de)
EP (1) EP0525307B1 (de)
JP (1) JP3470904B2 (de)
KR (1) KR100235550B1 (de)
CN (1) CN1046852C (de)
AT (1) ATE134873T1 (de)
AU (1) AU651229B2 (de)
BR (1) BR9202771A (de)
CA (1) CA2074348C (de)
DE (1) DE69208765T2 (de)
DK (1) DK0525307T3 (de)
ES (1) ES2086022T3 (de)
GR (1) GR3019234T3 (de)
HK (1) HK1000005A1 (de)
HU (1) HU220595B1 (de)
IE (1) IE74401B1 (de)
IL (1) IL102567A (de)
MX (1) MX9204135A (de)
NZ (1) NZ243619A (de)
TW (1) TW201696B (de)
ZA (1) ZA925522B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5686092A (en) * 1992-11-24 1997-11-11 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
DE4308282C2 (de) * 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
TR200103188T2 (tr) * 1999-05-07 2002-04-22 Pharmasol Gmbh Sıvı ve katı lipit karışımları temelli lipid parçacıklar.
KR20020011985A (ko) * 1999-05-07 2002-02-09 파르마솔 게엠베하 액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법
ES2304371T3 (es) * 2000-10-10 2008-10-16 Wyeth Holdings Corporation Composiciones estables para administracion parenteral.
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
BR112012008185A2 (pt) 2009-10-07 2016-08-16 Wyeth Llc composições que compreendem adjuvante, macrolídeo e antígeno proteináceo, e métodos para uso dessas composições
ITUB20153652A1 (it) 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
US11318156B2 (en) 2017-04-13 2022-05-03 Ceva Sante Animale Solid injectable veterinary implants comprising monocyclic lactone
KR20220013540A (ko) * 2019-02-21 2022-02-04 크로마덱스 아이엔씨. 니코틴아미드 리보사이드, 니코틴산 리보사이드, 환원 니코티닐 리보사이드 화합물, 및 니코티닐 리보사이드 화합물 유도체의 제형에서의 용도
EP3962448A1 (de) 2019-05-03 2022-03-09 Intervet International B.V. Injizierbare pharmazeutische zusammensetzungen und verwendungen davon
MX2022014493A (es) 2020-05-20 2022-12-13 Intervet Int Bv Composiciones farmaceuticas inyectables y usos de las mismas.
WO2022263505A1 (en) * 2021-06-16 2022-12-22 Société des Produits Nestlé S.A. Methods of solid phase wax coating of an active ingredient
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3659022A (en) * 1967-11-13 1972-04-25 Upjohn Co Methods of preventing impregnation
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US5169956A (en) * 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
US5106994A (en) * 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
DE3777721D1 (de) * 1986-08-11 1992-04-30 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
EP0385106B1 (de) * 1989-02-28 1994-03-23 American Cyanamid Company Bolus mit lang andauernder Wirkstoffabgabe, wirksam bei der Prophylaxe, Behandlung oder Bekämpfung des Befalls bei Wiederkäuern durch Fadenwürmer, Milben und Endo- und Ektoparasiten
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5346698A (en) * 1991-01-15 1994-09-13 Mycogen Corporation Synergistic pesticidal compositions
US5192546A (en) * 1991-01-15 1993-03-09 Mycogen Corporation Synergistic pesticidal compositions
US5185108A (en) * 1991-07-10 1993-02-09 The B. F. Goodrich Company Method for producing wax microspheres
JP4654917B2 (ja) 2006-01-12 2011-03-23 日産自動車株式会社 車体後部構造

Also Published As

Publication number Publication date
EP0525307A1 (de) 1993-02-03
MX9204135A (es) 1993-01-01
ZA925522B (en) 1993-04-28
CN1068735A (zh) 1993-02-10
ES2086022T3 (es) 1996-06-16
IL102567A0 (en) 1993-01-14
AU2047292A (en) 1993-01-28
GR3019234T3 (en) 1996-06-30
CA2074348C (en) 2004-02-17
KR930001904A (ko) 1993-02-22
HK1000005A1 (en) 1997-10-03
TW201696B (de) 1993-03-11
CN1046852C (zh) 1999-12-01
DE69208765D1 (de) 1996-04-11
DK0525307T3 (da) 1996-04-01
IE74401B1 (en) 1997-07-30
CA2074348A1 (en) 1993-01-24
US6340671B1 (en) 2002-01-22
HUT62454A (en) 1993-05-28
AU651229B2 (en) 1994-07-14
BR9202771A (pt) 1993-03-23
EP0525307B1 (de) 1996-03-06
IL102567A (en) 1996-10-31
KR100235550B1 (ko) 1999-12-15
DE69208765T2 (de) 1996-09-26
HU220595B1 (hu) 2002-03-28
IE922373A1 (en) 1993-01-27
JP3470904B2 (ja) 2003-11-25
HU9202404D0 (en) 1992-10-28
NZ243619A (en) 1994-12-22
JPH05194211A (ja) 1993-08-03

Similar Documents

Publication Publication Date Title
ATE134873T1 (de) Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung
NO2022019I1 (no) Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
KR880008986A (ko) D 계열 프로스타글란딘, 및 그를 함유하는 정신안정제와 최면제
KR900006330A (ko) 피롤로[3,2-e]피라졸로[1,5-a]피리미딘 유도체 및 이를 함유하는 약제
DK1383756T3 (da) Cumarinderivater til anvendelse som antikoagulanter
ATE207492T1 (de) Difluoroavermectin-derivate
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
HU9300202D0 (en) Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them
KR900701795A (ko) 티에노시클로 헵타피리다진 화합물과 그것의 의약용도
KR950701329A (ko) 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof)
ATE285771T1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
KR950703956A (ko) 순환 장애 개선제[circulatory disturbance ameliorant]
ES2132283T3 (es) Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
ATE236133T1 (de) Benzimidazolderivate
WO2001072289A3 (de) Arzneimittel zur stimulierung der leukopoese, zur behandlung von tumor- und protozoenerkrankungen, von akarinosis, arthropodiasis und verfahren zu seiner herstellung
ES2179667T3 (es) Nuevas formulaciones inyectables que contienen ramoplanina.
IT1215340B (it) Derivati di esteri dell'acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
KR890016970A (ko) 뇌 조직의 순환 혈액량 증가 조성물
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors
KR920701163A (ko) 퀴놀론 카르복실산 유도체
KR830006182A (ko) 신규한 옥시아세트산 유도체, 그의 제법 및 그것을 유효성분으로 하는 혈중지질 저하제(血中脂質低下劑)
KR880013910A (ko) 로다닌 유도체, 그의 제조방법 및 그를 함유하는 약학 조성물
KR890002159A (ko) 디히드로피리딘락톨 및 그의 의약품으로서의 용도
KR950011399A (ko) 살균성 인다닐아민 화합물, 이의 유도체 및 이들의 제조방법